| アブストラクト | OBJECTIVE: To compare potential risk factors for the diagnosis of psoriatic arthritis (PsA), psoriasis (PsO), rheumatoid arthritis (RA), and ankylosing spondylitis (AS). METHODS: Four parallel case-control studies were conducted within The Health Improvement Network using data between 1994 and 2015. Patients with PsA, PsO, RA, or AS were identified using validated code lists and matched to controls on age, sex, practice, and year. Risk factors were selected in the time prior to diagnosis. Multivariable logistic regression models were constructed for each disease using automated stepwise regression to test potential risk factors. RESULTS: Patients with incident PsA (n = 7594), PsO (n = 111,375), RA (n = 28,341), and AS (n = 3253) were identified and matched to 75,930, 1,113,345, 283,226, and 32,530 controls, respectively. Median diagnosis age was 48 (IQR 38-59), 43 (IQR 28-60), 60 (IQR 48-71), and 41 (IQR 32-54) years, respectively. In multivariable models, there were some shared and some differing risk factors across all 4 diseases: PsA was associated with obesity, pharyngitis, and skin infections; PsA and PsO were associated with obesity and moderate alcohol intake; PsA and AS were associated with uveitis; and PsA and RA were associated with preceding gout. Both RA and AS were associated with current smoking, former moderate drinking, anemia, osteoporosis, and inflammatory bowel disease. All shared former or current smoking as a risk factor; statin use was inversely associated with all 4 diseases. CONCLUSION: Shared and different risk factors for PsA, PsO, RA, and AS were identified. Statin use was inversely associated with all 4 conditions. |
|---|
| 投稿日 | 2021/8/3 |
|---|
| 投稿者 | Meer, Elana; Thrastardottir, Telma; Wang, Xingmei; Dubreuil, Maureen; Chen, Yong; Gelfand, Joel M; Love, Thorvardur J; Ogdie, Alexis |
|---|
| ジャーナル名 | The Journal of rheumatology |
|---|
| 組織名 | E. Meer, BA, Perelman School of Medicine, University of Pennsylvania,;Philadelphia, Pennsylvania, USA.;T. Thrastardottir, MPH, T.J. Love, MD, PhD, Department of Medicine/Rheumatology,;University of Iceland and Landspitali, Reykjavik, Iceland.;X. Wang, MD, Y. Chen, PhD, Department of Biostatistics, Epidemiology and;Informatics, Perelman School of Medicine, University of Pennsylvania,;M. Dubreuil, MD, Department of Medicine/Rheumatology, Boston University, Boston,;Massachusetts, USA.;J.M. Gelfand, MD, MSCE, Department of Biostatistics, Epidemiology and;Informatics, and Department of Dermatology, Perelman School of Medicine,;University of Pennsylvania, Philadelphia, Pennsylvania, USA.;A. Ogdie, MD, MSCE, Department of Biostatistics, Epidemiology and Informatics,;and Department of Medicine/Rheumatology, Perelman School of Medicine, University;of Pennsylvania, Philadelphia, Pennsylvania, USA. alogdie@pennmedicine.upenn.edu. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/34334358/ |
|---|
